Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOryx International Growth Regulatory News (OIG)

Share Price Information for Oryx International Growth (OIG)

Share Price is delayed by 15 minutes
Get Live Data
1,280.00    5.00 (0.39%)
Bid:
1,230.00
Ask:
1,305.00
Spread: 75.00 (6.098%)
Market Cap: £179.20m
OIG Live PriceLast checked at - London Stock Exchange

Intraday Oryx International Growth Share Chart

Interim Management Statement

10 Feb 2011 16:30

RNS Number : 0489B
Oryx International Growth Fund Ld
10 February 2011
 



ORYX INTERNATIONAL GROWTH FUND LIMITED

 

INTERIM MANAGEMENT STATEMENT FOR THE QUARTER ENDED 31 DECEMBER 2010

 

Oryx International Growth Fund Limited ("Oryx" or the "Company"), is publishing this Interim Management Statement in accordance with DTR 4.3 of the FSA Handbook.

 

This interim management statement has been produced solely to provide additional information to shareholders as a body to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied upon by any other party or for any other purpose.

 

This interim management statement relates to the period from 1 October 2010 to 31 December 2010, and contains information that covers this period, and up to the date of publication of this interim management statement, unless otherwise specified.

 

 

Manager's Review

 

The FTSE All-Share TR Index (£) returned 7.38% over the fourth quarter. Risk assets were in demand after the announcement of further quantitative easing in the United States and on the back of greater economic optimism, particularly on signs of recovery in the US economy. December was a particularly strong month for developed market equities including the UK stock market. Reflecting this increased risk appetite, the FTSE Small Cap TR Index outperformed the broad index, returning 9.05%. Against this backdrop, the Fund's NAV rose by 11.28%, while its share price advanced 20.25% to £2.375. The discount to NAV narrowed sharply from 21.72% at the start of the quarter to 15.41% at the end of December.

 

 

Material Transactions

Since 1 October 2010 the Company has purchased for cancellation the following shares:

 

12 November 2010 a total of 15,000 ordinary shares at a gross price of £2.10 per share.

19 November 2010 a total of 15,000 ordinary shares at a gross price of £2.10 per share.

10 December 2010 a total of 37,860 ordinary shares at a gross price of £2.15 per share.

 

 

Material Events

There were no material events during the quarter ended 31 December 2010.

 

 

Report and Accounts

On 11 November 2010, the Company posted its Interim Report for the six months ended 30 September 2010, to Shareholders.

 

 

Financial Highlights

 

 

31 December 2010

30 June 2010

31 March 2010

31 December 2009

 

 

 

 

 

NAV

£2.81

£2.35

£2.28

£2.26

 

 

 

 

 

US Dollar / Sterling Exchange Rate

 

1.5657

 

1.4961

 

1.5169

 

1.4378

 

 

 

 

 

 

 

Twenty Largest Equity Investments at 31 December 2010

 

%

Chrysalis Group Plc

9.66

Gleeson (M J) Group Plc

6.89

BBA Aviation Plc

6.71

CVS Group Plc

5.78

RPC Group Plc

5.25

Idox Plc

4.84

Quarto Group Inc

4.79

Catalyst Media Group Plc

4.46

Orthoproducts Ltd

4.41

Bavaria Industriekapital AG

4.30

Journey Group Plc

4.03

IS Pharma Plc

3.90

Phoenix Group Holdings

3.18

Augean

3.01

Innovation Group Plc

2.85

Focus Solutions Group Plc

2.76

Vislink Plc

2.63

Nastor Inv Ltd Zero Dividend Preference Shares

2.52

Assetco Plc

2.30

RPC Group Plc nrp rts 21/01/2011

1.93

% of total portfolio

86.20

 

The financial information for the quarter ended 31 December 2010 contained within this Interim Management Statement has not been audited.

 

 

By order of the Board

 

 

 

 

BNP Paribas Fund Services (Guernsey) Limited, for and on behalf of

Oryx International Growth Fund Limited

as Company Secretary

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUAPPUPGGQU
Date   Source Headline
9th Jan 20259:40 amRNSNet Asset Value(s)
9th Dec 202411:08 amRNSNet Asset Value(s)
6th Dec 20244:16 pmRNSHalf-year Report
11th Nov 20241:09 pmRNSNet Asset Value(s)
4th Nov 202412:50 pmRNSDirector/PDMR Shareholding
30th Oct 202410:52 amRNSOffer to acquire GYG Plc
30th Oct 20248:37 amRNSBid for Eckoh plc
8th Oct 20241:16 pmRNSNet Asset Value(s)
17th Sep 202412:10 pmRNSDirector/PDMR Shareholding
13th Sep 20243:19 pmRNSDirector/PDMR Shareholding
13th Sep 20243:16 pmRNSDirector/PDMR Shareholding
13th Sep 20249:42 amRNSDirector/PDMR Shareholding
12th Sep 20243:50 pmRNSDirector/PDMR Shareholding
12th Sep 20243:49 pmRNSDirector/PDMR Shareholding
9th Sep 202412:19 pmRNSNet Asset Value(s)
6th Sep 20242:01 pmRNSDirector/PDMR Shareholding
3rd Sep 20242:46 pmRNSDirector/PDMR Shareholding
2nd Sep 20244:27 pmRNSDirector/PDMR Shareholding
22nd Aug 202410:50 amRNSResult of AGM
9th Aug 20242:31 pmRNSDirector/PDMR Shareholding
8th Aug 202411:24 amRNSNet Asset Value(s)
1st Aug 20247:00 amRNSDirectorate Change
26th Jul 20244:00 pmRNSNotice of AGM
11th Jul 202410:24 amRNSNet Asset Value(s)
10th Jul 20247:00 amRNSInvestor Presentation
4th Jul 20247:00 amRNSAnnual Financial Report
11th Jun 202410:41 amRNSNet Asset Value(s)
10th May 20249:26 amRNSNet Asset Value(s)
10th Apr 20244:34 pmRNSNet Asset Value(s)
15th Mar 202410:01 amRNSHolding(s) in Company
8th Mar 20245:18 pmRNSNet Asset Value(s)
1st Mar 20249:48 amRNSDirector/PDMR Shareholding
26th Feb 202410:54 amRNSDirector/PDMR Shareholding
19th Feb 202411:51 amRNSDirector/PDMR Shareholding
13th Feb 20245:10 pmRNSDirector/PDMR Shareholding
7th Feb 202410:50 amRNSNet Asset Value(s)
18th Jan 20243:19 pmRNSDirector/PDMR Shareholding
15th Jan 20244:35 pmRNSHolding(s) in Company
9th Jan 20244:17 pmRNSNet Asset Value(s)
5th Jan 20249:21 amRNSDirector/PDMR Shareholding
15th Dec 202310:30 amRNSDirector Declaration
11th Dec 202312:52 pmRNSNet Asset Value(s)
21st Nov 202310:21 amRNSHalf-year Report
16th Nov 20238:59 amRNSProposed Sale of The City Pub Group plc
9th Nov 202310:20 amRNSNet Asset Value(s)
19th Oct 20239:00 amRNSInvestment Update
9th Oct 20232:40 pmRNSNet Asset Value(s)
6th Oct 202312:09 pmRNSUpdate on proposed bids for holdings
7th Sep 20235:02 pmRNSNet Asset Value(s)
24th Aug 202310:50 amRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.